Score Your Stock

US stock · figures in US dollars · scored on full-year results

Dexcom DexCom, Inc.

DXCM · Healthcare · Medical Devices
Top 7% of scored stocks
OkayTop 7% of scored stocks
Weak Spot

Dexcom scores 73/100 on fundamentals: in the top 7% of 503 scored S&P 500 stocks. Its strongest area is Business Strength (100/100); its weakest is Price Fairness (17/100). It carries 1 warning flag: Weak Spot.

Best
Business 100
Risk 100
Weakest
Price 17
  • Carries a Weak Spot flag

A financially strong, expensively priced stock with healthy growth, but price fairness needs attention.

What looks good
What to watch
Mkt capUS$ 31.1b#315 of 503 in the S&P 500EPSUS$ 2.52P/E31×✗ vs sector median 29.6×P/B12.1×✗ vs sector median 3.7×Div yieldNo dividends paidBottom 12% in the S&P 50052w range · 74% of range54.1192.59
as of 31 Oct 2026

Nearby peers

Ranks #4 of 60 in Healthcare by score

#1Universal Health Services79#2ResMed77#3Steris75
#4Dexcom73
#5Insulet71#6Boston Scientific68

One-Minute Summary

Why Dexcom scores 73

A financially strong, expensively priced stock with healthy growth, but price fairness needs attention.

What looks good
What to watch

Business Strength

100
Why 100?
Pillar score: (2 + 2 + 2 + 2 + 2) = 10 of 10 points → 100
Return on Equity (ROE)39%Strong4-Year Revenue Growth+12%/yrStrong4-Year Profit Growth+22%/yrStrongNet Profit Margin19%StrongQuarterly Momentum+16%Strong
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↑ +83%Equity ↑ +22.6%ROE % 39.1%
Net ProfitEquityROE %
542m576m836m991m2.1b2.1b2.7b2.5b202320242025TTM26.2%27.4%30.5%39.1%

Revenue & Net Profit, with Net Margin

Revenue ↑ +40.9%Net Profit ↑ +83%Net Margin % 19.4%
RevenueNet ProfitNet Margin %
3.6b4.0b4.7b5.1b542m576m836m991m202320242025TTM14.9%14.3%17.9%19.4%

Sales grew about 40.9% over 4 years: customers keep spending more with this company.

Profit climbed about 83% over 4 years: the business keeps more money as it grows.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↑ +31.6%Net Profit ↑ +85.1%Net Margin % 19%
RevenueNet ProfitNet Margin %
994m1.1b1.0b1.2b1.2b1.3b1.2b1.3b135m152m105m180m284m267m200m249mQ3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'2613.5%13.6%10.2%15.5%23.5%21.2%16.7%19%
▲▼▼▲▲▲▲▲

Sales grew about 31.6% over the last 8 quarters: customers keep spending more with this company.

Profit grew about 85.1% over the last 8 quarters: the business is keeping more of what it earns.

Why 83?
Pillar score: (1 + 2 + 2) = 5 of 6 points → 83
Debt-to-Equity0.6×OkayCurrent Ratio1.7×StrongInterest Coverage95.2×Strong
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↓ -46.3%Equity ↑ +22.6%D/E 0.5×
Total DebtEquityD/E
2.6b2.6b1.4b1.4b2.1b2.1b2.7b2.5b202320242025TTM1.3×1.2×0.5×0.5×

Borrowings fell about 46.3% over 4 years: the company is steadily getting safer.

Short-term assets vs bills, with Current Ratio

Current Assets ↓ -11.5%Current Liabilities ↑ +44.8%Current Ratio 1.7×
Current AssetsCurrent LiabilitiesCurrent Ratio
4.4b4.3b4.0b3.9b1.6b2.9b2.1b2.3b202320242025TTM2.8×1.5×1.9×1.7×
Why 63?
Pillar score: (0 + 2 + 2 + 1) = 5 of 8 points → 63
Dividend QualityNo dividends paidWeak
Payout ratio: 0%
Operating Cash FlowPositive & growingStrongFree Cash FlowPositive & growingStrongCash & Cash EquivalentsPartly healthyOkay
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↑ +195.2%Free CF ↑ +238.3%
Operating CFFree CF
749m990m1.4b2.2b512m631m1.1b1.7b202320242025TTM

The business generates real cash, and more of it each year: a very healthy sign.

Cash vs Total Debt

Cash ↑ +69.8%Total Debt ↓ -46.3%
CashTotal Debt
566m606m918m961m2.6b2.6b1.4b1.4b202320242025TTM

Dividends per Share, with Yield

DPS (cents) → +0%Yield % 0%
DPS (cents)Yield %
000020222023202420250%0%0%0%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 17?
Pillar score: (0 + 0 + 1) = 1 of 6 points → 17
P/E Ratio31×WeakP/B Ratio12.1×WeakPEG Ratio1.4Okay
Show chart

Share Price: Weekly Closes (not part of the score)

US$ 92.34US$ 73.67US$ 55.00Oct '25Feb '26Jun '26Oct '26

The share price is up about 41.3% over the past year.

Why 100?
Pillar score: (2 + 2 + 2 + 2 + 2 + 2) = 12 of 12 points → 100
Earnings ConsistencySteadyStrongDebt Trend (4yr)FallingStrongShare Count Trend (4yr)-1%/yrStrongInventory vs Sales (4yr)-0.8 pp/yr vs salesStrongAsset Turnover Trend (4yr)+41.5%StrongQuarterly Consistency0 of 4 quarters downStrong
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +40.9%Inventory ↑ +37.7%Inv. % of Rev. 15.1%
RevenueInventoryInv. % of Rev.
3.6b4.0b4.7b5.1b560m543m629m771m202320242025TTM15.4%13.5%13.5%15.1%
Ranks #4 of 60 in Healthcare by score

Sector peers

#1Universal Health Services79#2ResMed77#3Steris75
#4Dexcom (you)73
#5Insulet71#6Boston Scientific68

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDiv yieldP/E RatioP/B RatioPEG Ratio
2026US$ 5.1bUS$ 991.0mUS$ 2.2bUS$ 1.7bUS$ -477.4mUS$ 961.4mUS$ 1.4b-US$ 2.5bUS$ 3.9bUS$ 2.3bUS$ 6.2bUS$ 3.7bUS$ 770.7m-39%19%0.6×1.7×95.2×----
2025US$ 4.7bUS$ 836.3mUS$ 1.4bUS$ 1.1bUS$ -363.5mUS$ 917.7mUS$ 1.4b-US$ 2.7bUS$ 4.0bUS$ 2.1bUS$ 6.3bUS$ 3.6bUS$ 629.1mUS$ 0.0m30%18%0.5×1.9×60.5×0%30.6×9.3×0.9
2024US$ 4.0bUS$ 576.2mUS$ 989.5mUS$ 630.7mUS$ -358.8mUS$ 606.1mUS$ 2.6bUS$ 1.2bUS$ 2.1bUS$ 4.3bUS$ 2.9bUS$ 6.5bUS$ 4.4bUS$ 542.6mUS$ 0.0m27%14%1.2×1.5×38.3×0%55.0×15.1×1.8
2023US$ 3.6bUS$ 541.5mUS$ 748.5mUS$ 511.9mUS$ -236.6mUS$ 566.3mUS$ 2.6b-US$ 2.1bUS$ 4.4bUS$ 1.6bUS$ 6.3bUS$ 4.2bUS$ 559.6mUS$ 0.0m26%15%1.3×2.8×36.0×0%88.3×23.1×1.5